Transcatheter Aortic Valve Replacement in Young Low-Risk Patients With Severe Aortic Stenosis: A Review
In the last decades, transcatheter aortic valve replacement (TAVR) revolutionized the treatment of symptomatic severe aortic stenosis.The efficacy and safety of TAVR were first proven in inoperable and high-risk patients.Then, subsequent randomized clinical trials showed non-inferiority of TAVR as compared to surgical aortic valve replacement also